Dr. Frederick has served on our Board of Directors since October 2020. He is the President Emeritus of Howard University, having previously served as the President from July 2014 to September 2023, and the distinguished Charles R. Drew Professor of Surgery at the Howard University College of Medicine. Prior to being appointed president in 2014, Dr. Frederick served as Howard University’s Provost and Chief Academic Officer.
Dr. Frederick is a practicing surgeon, distinguished researcher and scholar, and the author of numerous peer-reviewed articles, book chapters, abstracts, and editorials. He has received several awards for his scholarship and public service and continues lectures to medical students and residents of Howard’s College of Medicine. Dr. Frederick belongs to numerous surgical organizations, including the American Surgical Association, and is a member of the American College of Surgeons Academy of Master Surgeon Educators and the National Academy of Medicine.
As a widely recognized expert on disparities in healthcare and medical education, his medical research focuses on narrowing racial, ethnic, and gender disparities in cancer care outcomes among African Americans and other underrepresented groups. Dr. Frederick has served as the principal investigator for major collaborations with the National Cancer Institute and Johns Hopkins University, as well as several national minority-serving oncology programs.
He received his Bachelor of Science, Doctor of Medicine, and Master of Business Administration from Howard University. Dr. Frederick also serves on the Board of Directors of Agostini’s Limited, Humana Inc., Tempus AI, Inc., and Workday, Inc., as well as Mutual of America Life Insurance Company and other privately held companies and charitable organizations.
Dr. Frederick’s vast experience in medical research, healthcare academics, and business administration brings valuable insights to Insulet’s Board.
How do I contact Wayne A.I. Frederick?
Has Wayne A.I. Frederick been buying or selling shares of Insulet?
Who are Insulet's active insiders?
Insulet's insider roster includes Charles Alpuche (COO), Eric Benjamin (SVP), Luciana Borio (Director), Lauren Budden (Group Vice President, CAO and Controller), Bret Christensen (EVP), Sally Crawford (Director), John Fallon (Director), Mark Field (SVP and Chief Technology Officer), Wayne Frederick (Director), James Hollingshead (CEO), Dan Manea (SVP), Wayde McMillan (CFO), Shacey Petrovic (CEO), Timothy Scannell (Director), Prem Singh (SVP), and Michael Spears (SVP). Learn More on Insulet's active insiders.
Are insiders buying or selling shares of Insulet?
In the last twelve months, insiders at the medical instruments supplier sold shares 7 times. They sold a total of 29,065 shares worth more than $6,860,673.63. The most recent insider tranaction occured on March, 25th when Director Wayne A.I. Frederick sold 1,825 shares worth more than $501,875.00. Insiders at Insulet own 0.5% of the company.
Learn More about insider trades at Insulet. Information on this page was last updated on 3/25/2025.
